The “baseline-upregulation” of the RAS in the setting of advanced cirrhosis may facilitate SARS-CoV-2 cell entry due to decreased antiplasmin activity and consecutively elevated plasmin levels. This evidence concerns the gene PLG and Cirrhosis.